Search

Your search keyword '"Phenols -- Intellectual property"' showing total 82 results
Start Over Descriptor "Phenols -- Intellectual property" Topic women's issues/gender studies
82 results on '"Phenols -- Intellectual property"'

3. Researchers Submit Patent Application, 'Small Molecule Degraders Of Estrogen Receptor With Cereblon Ligands', for Approval (USPTO 20240190880)

Subjects
Women -- Health aspects, Biochemistry, Phenols -- Intellectual property, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Acharyya, [...]

Published
2024

4. Patent Issued for Estrogen receptor modulators (USPTO 11999728)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Bunker, Kevin Duane (Escondido, CA, US), Hegde, Sayee Gajanan [...]

Published
2024

5. Patent Issued for Selective estrogen receptor degraders (USPTO 11993608)

Subjects
Eli Lilly and Co. -- Intellectual property, Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Eli Lilly and Company (Indianapolis, Indiana, United States) has been issued patent number 11993608, [...]

Published
2024

6. Patent Application Titled 'Therapeutic Targeting Of Receptor Tyrosine Kinase Inhibitor-Induced Androgen Receptor Phosphorylation In Cancer' Published Online (USPTO 20240165078)

Subjects
Women -- Health aspects, Tyrosine -- Intellectual property, Prostate cancer, Nilotinib, Antineoplastic agents -- Intellectual property, Tofacitinib, Phenols -- Intellectual property, Cancer, Antimitotic agents -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JUN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2024

8. Patent Issued for Processes for the preparation of selective estrogen receptor degraders (USPTO 11926634)

Subjects
Eli Lilly and Co. -- Intellectual property, Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Arguelles Delgado, Alonso Jose (Indianapolis, IN, US), Czeskis, Boris [...]

Published
2024

9. Patent Issued for Salts of selective estrogen receptor degraders (USPTO 11903931)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies, L-Lysine (Dietary supplement) -- Intellectual property
Abstract

2024 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Inventisbio Co. Ltd. (Shanghai, People's Republic of China) has been issued patent number 11903931, [...]

Published
2024

10. Patent Issued for Estrogen therapy for brain gray matter atrophy and associated disability (USPTO 11865122)

Subjects
Women -- Health aspects, Tizanidine -- Intellectual property, Multiple sclerosis, Phenols -- Intellectual property, Estrogen, Health, Women's issues/gender studies
Abstract

2024 FEB 1 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- University of California (Oakland, California, United States) has been issued patent number 11865122, according [...]

Published
2024

11. Researchers Submit Patent Application, 'Use Of Combined Oral Contraceptives Containing Nomegestrol Acetate And Estradiol', for Approval (USPTO 20230398127)

Subjects
Estradiol -- Intellectual property, Women -- Health aspects, Drospirenone -- Intellectual property, Phenols -- Intellectual property, Contraceptives -- Intellectual property, Acetates -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JAN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor BOOLELL, [...]

Published
2024

12. Researchers Submit Patent Application, 'Methods Of Contraception Using Nomegestrol Acetate And Estradiol', for Approval (USPTO 20230390306)

Subjects
Estradiol -- Intellectual property, Women -- Health aspects, Drospirenone -- Intellectual property, Phenols -- Intellectual property, Contraceptives -- Intellectual property, Norgestimate -- Intellectual property, Transdermal medication -- Intellectual property, Acetates -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 DEC 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor BOOLELL, [...]

Published
2023

13. Researchers Submit Patent Application, 'Substituted Benzothiophene Analogs As Selective Estrogen Receptor Degraders', for Approval (USPTO 20230381137)

Subjects
Women -- Health aspects, Biochemistry, Thiophene, Antineoplastic agents -- Intellectual property, Phenols -- Intellectual property, Estrogen, Antimitotic agents -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 DEC 21 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors GUTGESELL, [...]

Published
2023

14. 'Treatment Of Er-Negative Breast Cancer With An Pdgf-Cc Inhibitor And An Anti-Estrogen' in Patent Application Approval Process (USPTO 20230310385)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Platelet-derived growth factor, Estrogen, Breast cancer, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 OCT 26 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Eriksson, Ulf (Balsta, SE); Pietras, Kristian (Vellinge, SE); [...]

Published
2023

16. Patent Application Titled 'Identification Of Estrogen Receptor Positive (Er+) Breast Cancers That Will Not Develop Tamoxifen Resistance' Published Online (USPTO 20230279502)

Subjects
Tamoxifen -- Intellectual property, Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Breast cancer, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 SEP 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2023

17. Patent Issued for 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity (USPTO 11660303)

Subjects
Women -- Health aspects, Tyrosine -- Intellectual property, Phenols -- Intellectual property, B cells, Amines, Health, Women's issues/gender studies
Abstract

2023 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Bystrom, Styrbjorn (Taby, SE), Mellstedt, Hakan (Stockholm, SE), Olsson, [...]

Published
2023

18. Patent Application Titled 'N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases' Published Online (USPTO 20230142839)

Subjects
Array BioPharma Inc. -- Intellectual property, Women -- Health aspects, Tyrosine -- Intellectual property, Phenols -- Intellectual property, Amines, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 JUN 1 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2023

19. Patent Issued for Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating cancer (USPTO 11642342)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Hormones, Cancer -- Care and treatment, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 JUN 1 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Fan, Jie (Brooklyn, NY, US), He, Wei (Zionsville, IN, [...]

Published
2023

20. Patent Issued for Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen (USPTO 11633382)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Platelet-derived growth factor, Estrogen, Breast cancer, Health, Women's issues/gender studies
Abstract

2023 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Paracrine Therapeutics AB (Balsta, Sweden) has been issued patent number 11633382, according to news [...]

Published
2023

21. Patent Issued for Selective estrogen receptor degraders (USPTO 11634426)

Subjects
Eli Lilly and Co. -- Intellectual property, Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Eli Lilly and Company (Indianapolis, Indiana, United States) has been issued patent number 11634426, [...]

Published
2023

22. 'Use Of Quinazoline-Based Tyrosine Kinase Inhibitors For The Treatment Of Cancers With Nrg1 Fusions' in Patent Application Approval Process (USPTO 20230121116)

Subjects
Women -- Health aspects, Tyrosine -- Intellectual property, Phenols -- Intellectual property, Pertuzumab, Cancer -- Care and treatment, Health, Women's issues/gender studies
Abstract

2023 MAY 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors HEYMACH, John (Houston, TX, US); ROBICHAUX, Jacqulyne (Houston, [...]

Published
2023

23. Patent Issued for Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders (USPTO 11597720)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Hormones, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 MAR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2023

25. 'Protein Markers For Estrogen Receptor (Er)-Positive-Like And Estrogen Receptor (Er)-Negative-Like Breast Cancer' in Patent Application Approval Process (USPTO 20230059578)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Breast cancer, Biological markers, Health, Women's issues/gender studies
Abstract

2023 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Campbell, Jamie Leigh (Bethesda, MD, US); Cutler, Mary [...]

Published
2023

26. Patent Issued for Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer (USPTO 11547705)

Subjects
Endothelial growth factors, Women -- Health aspects, Tyrosine -- Intellectual property, Phenols -- Intellectual property, Cancer -- Care and treatment, Health, Women's issues/gender studies
Abstract

2023 FEB 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Merck Sharp & Dohme LLC (Rahway, New Jersey, United States) has been issued patent [...]

Published
2023

28. 'Tetrahydronaphthalene And Tetrahydroisoquinoline Derivatives As Estrogen Receptor Degraders' in Patent Application Approval Process (USPTO 20220388984)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 DEC 29 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors Crew, Andrew P. (Guilford, CT, US); Dong, Hanqing [...]

Published
2022

31. Patent Application Titled 'Tetrahydronaphthalene And Tetrahydroisoquinoline Derivatives As Estrogen Receptor Degraders' Published Online (USPTO 20220274955)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Hormones, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2022

34. Patent Issued for Estrogen receptor-modulating compounds (USPTO 11384068)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 AUG 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Miller, Chris (San Mateo, CA, US), filed on January [...]

Published
2022

35. Patent Application Titled 'Novel Compounds Having Bet, Estrogen Receptor, And Androgen Receptor Degradation Activity And Uses Thereof' Published Online (USPTO 20220220124)

Subjects
Women -- Health aspects, Antineoplastic agents -- Intellectual property, Phenols -- Intellectual property, Proteins, Estrogen, Antimitotic agents -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 AUG 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2022

36. Patent Application Titled 'Novel Salts Of Selective Estrogen Receptor Degraders' Published Online (USPTO 20220202790)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Tromethamine -- Intellectual property, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies, L-Lysine (Dietary supplement) -- Intellectual property
Abstract

2022 JUL 21 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2022

37. Researchers Submit Patent Application, 'Benzothiophene-Based Selective Estrogen Receptor Downregulator Compounds', for Approval (USPTO 20220194917)

Subjects
Biochemistry, Women -- Health aspects, Thiophene, Phenols -- Intellectual property, Hormones, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Thatcher, [...]

Published
2022

38. Patent Issued for Estrogen receptor modulators (USPTO 11339162)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 JUN 16 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Bunker, Kevin Duane (Escondido, CA, US), Hegde, Sayee Gajanan [...]

Published
2022

39. Researchers Submit Patent Application, 'Estrogen Receptor Protein Degraders', for Approval (USPTO 20220079931)

Subjects
Biochemistry, Women -- Health aspects, Disodium pamidronate -- Intellectual property, Antineoplastic agents -- Intellectual property, Phenols -- Intellectual property, Estrogen, Antimitotic agents -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 APR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Hu, [...]

Published
2022

40. Patent Application Titled 'Crystalline And Amorphous Forms Of A Compound For The Targeted Degradation Of Estrogen Receptor' Published Online (USPTO 20220081416)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 APR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2022

43. Researchers Submit Patent Application, 'MEDICATION AGAINST ESTROGEN-RECEPTOR b (ER.beta) POSITIVE BREAST TUMOR', for Approval (USPTO 20220054501)

Subjects
Biochemistry, Women -- Health aspects, Phenols -- Intellectual property, Colorectal cancer, Breast cancer, Health, Women's issues/gender studies
Abstract

2022 MAR 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor Wieland, [...]

Published
2022

44. 'Combination Therapy For The Treatment Of Estrogen-Receptor Positive Breast Cancer' in Patent Application Approval Process (USPTO 20220047563)

Subjects
Women -- Health aspects, Antineoplastic agents -- Intellectual property, Phenols -- Intellectual property, Estrogen, Breast cancer, Antimitotic agents -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 MAR 10 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors CAMPEAU, Eric (Calgary, CA); KHARENKO, Olesya (Calgary, CA); [...]

Published
2022

45. 'Combination Of A Pd-1 Antagonist And A Vegfr/Fgfr/Ret Tyrosine Kinase Inhibitor For Treating Cancer' in Patent Application Approval Process (USPTO 20220023285)

Subjects
Merck Sharp & Dohme Corp. -- Intellectual property, Women -- Health aspects, Tyrosine -- Intellectual property, Phenols -- Intellectual property, Cancer -- Care and treatment, Palladium -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2022 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventors DENKER, Andrew Evan (North Wales, PA, US); HORI, [...]

Published
2022

47. Patent Issued for Quinazoline analogs as receptor tyrosine kinase inhibitors (USPTO 11174273)

Subjects
Array BioPharma Inc. -- Intellectual property, Women -- Health aspects, Tyrosine -- Intellectual property, Phenols -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 DEC 9 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by [...]

Published
2021

48. 'Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen' in Patent Application Approval Process (USPTO 20210346397)

Subjects
Women -- Health aspects, Drospirenone -- Intellectual property, Phenols -- Intellectual property, Norgestimate -- Intellectual property, Contraceptives -- Intellectual property, Drug approval, Estrogen, Health, Women's issues/gender studies
Abstract

2021 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent application by the inventor RUBIN, Arkady (Flemington, NJ, US), filed on July [...]

Published
2021

50. Patent Application Titled 'Quinazoline Analogs As Receptor Tyrosine Kinase Inhibitors' Published Online (USPTO 20210284656)

Subjects
Array BioPharma Inc. -- Intellectual property, Women -- Health aspects, Tyrosine -- Intellectual property, Phenols -- Intellectual property, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2021 OCT 7 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results